Genetic Manipulation of Mycoplasma pneumoniae.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2023
Historique:
entrez: 26 2 2023
pubmed: 27 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Mycoplasma pneumoniae is a small cell wall-lacking bacterium that is a common cause of bronchitis and pneumonia in humans. In addition to its clinical importance, M. pneumoniae has recently been considered a promising model organism for synthetic biology because of its small genome size and unique cell structure. At one cell pole, M. pneumoniae forms the attachment organelle that is responsible for adherence to host cells and gliding motility. The attachment organelle is a membrane protrusion and is composed of number of molecules, including adhesin and cytoskeletal proteins. Genetic manipulation techniques are key research approaches for understanding the structure and the function of this unique molecular machinery. In this chapter, standard genetic engineering methods for this species using the Tn4001 transposon vector are described.

Identifiants

pubmed: 36842129
doi: 10.1007/978-1-0716-3060-0_29
doi:

Substances chimiques

Adhesins, Bacterial 0
Cytoskeletal Proteins 0
Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-357

Informations de copyright

© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Mahairas GG, Minion FC (1989) Random insertion of the gentamicin resistance transposon Tn4001 in Mycoplasma pulmonis. Plasmid 21(1):43–47. https://doi.org/10.1016/0147-619x(89)90085-1
doi: 10.1016/0147-619x(89)90085-1 pubmed: 2543007
Kenri T, Seto S, Horino A et al (2004) Use of fluorescent-protein tagging to determine the subcellular localization of Mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus. J Bacteriol 186(20):6944–6955. https://doi.org/10.1128/JB.186.20.6944-6955.2004
doi: 10.1128/JB.186.20.6944-6955.2004 pubmed: 15466048 pmcid: 522203
Krause DC, Proft T, Hedreyda CT et al (1997) Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence. J Bacteriol 179(8):2668–2677. https://doi.org/10.1128/jb.179.8.2668-2677.1997
doi: 10.1128/jb.179.8.2668-2677.1997 pubmed: 9098066 pmcid: 179017
Reddy SP, Rasmussen WG, Baseman JB (1996) Isolation and characterization of transposon Tn4001-generated, cytadherence-deficient transformants of Mycoplasma pneumoniae and Mycoplasma genitalium. FEMS Immunol Med Microbiol 15(4):199–211. https://doi.org/10.1111/j.1574-695X.1996.tb00086.x
doi: 10.1111/j.1574-695X.1996.tb00086.x pubmed: 8908481
Hutchison CA, Peterson SN, Gill SR et al (1999) Global transposon mutagenesis and a minimal Mycoplasma genome. Science (New York, NY) 286(5447):2165–2169. https://doi.org/10.1126/science.286.5447.2165
doi: 10.1126/science.286.5447.2165
Hedreyda CT, Lee KK, Krause DC (1993) Transformation of Mycoplasma pneumoniae with Tn4001 by electroporation. Plasmid 30(2):170–175. https://doi.org/10.1006/plas.1993.1047
doi: 10.1006/plas.1993.1047 pubmed: 8234492
Knudtson KL, Minion FC (1993) Construction of Tn4001lac derivatives to be used as promoter probe vectors in mycoplasmas. Gene 137(2):217–222. https://doi.org/10.1016/0378-1119(93)90009-r
doi: 10.1016/0378-1119(93)90009-r pubmed: 8299950
Hahn TW, Mothershed EA, Waldo RH et al (1999) Construction and analysis of a modified Tn4001 conferring chloramphenicol resistance in Mycoplasma pneumoniae. Plasmid 41(2):120–124. https://doi.org/10.1006/plas.1998.1387
doi: 10.1006/plas.1998.1387 pubmed: 10087215
Montero-Blay A, Miravet-Verde S, Lluch-Senar M et al (2019) SynMyco transposon: engineering transposon vectors for efficient transformation of minimal genomes. DNA Res 26(4):327–339. https://doi.org/10.1093/dnares/dsz012
doi: 10.1093/dnares/dsz012 pubmed: 31257417 pmcid: 6704405
Pour-El I, Adams C, Minion FC (2002) Construction of mini-Tn4001tet and its use in Mycoplasma gallisepticum. Plasmid 47(2):129–137. https://doi.org/10.1006/plas.2001.1558
doi: 10.1006/plas.2001.1558 pubmed: 11982334
Reece-Hoyes JS, Walhout AJM (2018) Gateway recombinational cloning. Cold Spring Harb Protoc 2018(1). https://doi.org/10.1101/pdb.top094912
Miyata M, Robinson RC, Uyeda TQP et al (2020) Tree of motility – a proposed history of motility systems in the tree of life. Genes Cells 25(1):6–21. https://doi.org/10.1111/gtc.12737
doi: 10.1111/gtc.12737 pubmed: 31957229 pmcid: 7004002
Miyata M, Hamaguchi T (2016) Integrated information and prospects for gliding mechanism of the pathogenic bacterium Mycoplasma pneumoniae. Front Microbiol 7:960. https://doi.org/10.3389/fmicb.2016.00960
doi: 10.3389/fmicb.2016.00960 pubmed: 27446003 pmcid: 4923136
Kenri T, Suzuki M, Sekizuka T et al (2020) Periodic genotype shifts in clinically prevalent Mycoplasma pneumoniae strains in Japan. Front Cell Infect Microbiol 10:385. https://doi.org/10.3389/fcimb.2020.00385
doi: 10.3389/fcimb.2020.00385 pubmed: 32850484 pmcid: 7424021
Nakane D, Murata K, Kenri T et al (2021) Molecular ruler of the attachment organelle in Mycoplasma pneumoniae. PLoS Pathog 17(6):e1009621. https://doi.org/10.1371/journal.ppat.1009621
doi: 10.1371/journal.ppat.1009621 pubmed: 34111235 pmcid: 8191905
Nakane D, Kenri T, Matsuo L et al (2015) Systematic structural analyses of attachment organelle in Mycoplasma pneumoniae. PLoS Pathog 11(12):e1005299. https://doi.org/10.1371/journal.ppat.1005299
doi: 10.1371/journal.ppat.1005299 pubmed: 26633540 pmcid: 4669176
Hayflick L (1965) Tissue cultures and mycoplasmas. Tex Rep Biol Med 23(Suppl 1):285–303
Vizarraga D, Kawamoto A, Matsumoto U et al (2020) Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae. Nat Commun 21(1):5188. https://doi.org/10.1038/s41467-020-18777-y
doi: 10.1038/s41467-020-18777-y

Auteurs

Tsuyoshi Kenri (T)

Department of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan. kenri@niid.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH